nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—bile duct—bile duct cancer	0.132	0.161	CbGeAlD
Lamivudine—ABCC2—bile duct—bile duct cancer	0.105	0.128	CbGeAlD
Lamivudine—ABCC2—bile—bile duct cancer	0.081	0.0986	CbGeAlD
Lamivudine—PCYT2—liver—bile duct cancer	0.0395	0.048	CbGeAlD
Lamivudine—PGK1—liver—bile duct cancer	0.0339	0.0412	CbGeAlD
Lamivudine—NME1-NME2—liver—bile duct cancer	0.0309	0.0376	CbGeAlD
Lamivudine—NT5C—liver—bile duct cancer	0.0286	0.0348	CbGeAlD
Lamivudine—ABCC3—gall bladder—bile duct cancer	0.0281	0.0342	CbGeAlD
Lamivudine—CMPK1—pancreas—bile duct cancer	0.0272	0.0331	CbGeAlD
Lamivudine—PCYT1A—liver—bile duct cancer	0.0269	0.0327	CbGeAlD
Lamivudine—NME2—pancreas—bile duct cancer	0.0266	0.0323	CbGeAlD
Lamivudine—NME1-NME2—lymph node—bile duct cancer	0.0237	0.0288	CbGeAlD
Lamivudine—NT5C—lymph node—bile duct cancer	0.022	0.0267	CbGeAlD
Lamivudine—NME1—liver—bile duct cancer	0.018	0.0219	CbGeAlD
Lamivudine—CMPK1—liver—bile duct cancer	0.0173	0.0211	CbGeAlD
Lamivudine—NME2—liver—bile duct cancer	0.0169	0.0206	CbGeAlD
Lamivudine—NME1—lymph node—bile duct cancer	0.0138	0.0168	CbGeAlD
Lamivudine—DCK—pancreas—bile duct cancer	0.0135	0.0165	CbGeAlD
Lamivudine—CMPK1—lymph node—bile duct cancer	0.0133	0.0161	CbGeAlD
Lamivudine—NME2—lymph node—bile duct cancer	0.013	0.0158	CbGeAlD
Lamivudine—ABCC4—pancreas—bile duct cancer	0.0107	0.013	CbGeAlD
Lamivudine—DCK—liver—bile duct cancer	0.00862	0.0105	CbGeAlD
Lamivudine—ABCC3—liver—bile duct cancer	0.00825	0.01	CbGeAlD
Lamivudine—ABCC4—Ectoderm Differentiation—PPFIBP2—bile duct cancer	0.00763	0.0429	CbGpPWpGaD
Lamivudine—SLC22A1—liver—bile duct cancer	0.00735	0.00894	CbGeAlD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00717	0.0403	CbGpPWpGaD
Lamivudine—SLC22A3—liver—bile duct cancer	0.00703	0.00855	CbGeAlD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.00692	0.0389	CbGpPWpGaD
Lamivudine—ABCC4—liver—bile duct cancer	0.00681	0.00829	CbGeAlD
Lamivudine—DCK—lymph node—bile duct cancer	0.00661	0.00804	CbGeAlD
Lamivudine—ABCC2—liver—bile duct cancer	0.00659	0.00802	CbGeAlD
Lamivudine—ABCC3—lymph node—bile duct cancer	0.00633	0.0077	CbGeAlD
Lamivudine—ABCC1—liver—bile duct cancer	0.00581	0.00707	CbGeAlD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00544	0.0306	CbGpPWpGaD
Lamivudine—SLC22A3—lymph node—bile duct cancer	0.00539	0.00655	CbGeAlD
Lamivudine—ABCC4—lymph node—bile duct cancer	0.00522	0.00635	CbGeAlD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.00515	0.029	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—SMAD4—bile duct cancer	0.0051	0.0286	CbGpPWpGaD
Lamivudine—ABCC2—lymph node—bile duct cancer	0.00506	0.00615	CbGeAlD
Lamivudine—ABCG2—liver—bile duct cancer	0.00481	0.00585	CbGeAlD
Lamivudine—ABCC1—lymph node—bile duct cancer	0.00445	0.00542	CbGeAlD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—bile duct cancer	0.00441	0.0248	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—SMAD4—bile duct cancer	0.00386	0.0217	CbGpPWpGaD
Lamivudine—ABCB1—pancreas—bile duct cancer	0.00373	0.00453	CbGeAlD
Lamivudine—ABCG2—lymph node—bile duct cancer	0.00369	0.00449	CbGeAlD
Lamivudine—NT5C—Metabolism—FAR2—bile duct cancer	0.00319	0.018	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—FAR2—bile duct cancer	0.00319	0.018	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—FAR2—bile duct cancer	0.00319	0.018	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00301	0.0169	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—FAR2—bile duct cancer	0.0026	0.0146	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—MMP9—bile duct cancer	0.00245	0.0138	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—FAR2—bile duct cancer	0.00242	0.0136	CbGpPWpGaD
Lamivudine—ABCB1—liver—bile duct cancer	0.00237	0.00288	CbGeAlD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00228	0.0128	CbGpPWpGaD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—bile duct cancer	0.00223	0.0125	CbGpPWpGaD
Lamivudine—NME2—Metabolism—FAR2—bile duct cancer	0.00221	0.0124	CbGpPWpGaD
Lamivudine—ABCC1—S1P1 pathway—PTGS2—bile duct cancer	0.00206	0.0116	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.00191	0.0107	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—MMP9—bile duct cancer	0.00185	0.0104	CbGpPWpGaD
Lamivudine—ABCB1—lymph node—bile duct cancer	0.00182	0.00221	CbGeAlD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—bile duct cancer	0.00179	0.0101	CbGpPWpGaD
Lamivudine—NME1—Metabolism—FAR2—bile duct cancer	0.00168	0.00943	CbGpPWpGaD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.00166	0.00933	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—IDH2—bile duct cancer	0.00156	0.00877	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—IDH2—bile duct cancer	0.00156	0.00877	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—IDH2—bile duct cancer	0.00156	0.00877	CbGpPWpGaD
Lamivudine—PGK1—Disease—RNF43—bile duct cancer	0.00152	0.00853	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.0015	0.00843	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—HGF—bile duct cancer	0.00139	0.00781	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—IDH1—bile duct cancer	0.00134	0.00754	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—IDH1—bile duct cancer	0.00134	0.00754	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—IDH1—bile duct cancer	0.00134	0.00754	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00132	0.00744	CbGpPWpGaD
Lamivudine—PGK1—Disease—IDH1—bile duct cancer	0.00131	0.00734	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—IDH2—bile duct cancer	0.00127	0.00715	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—TP53—bile duct cancer	0.00126	0.00707	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—SLC5A5—bile duct cancer	0.00123	0.00694	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.00122	0.00688	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—IDH2—bile duct cancer	0.00118	0.00665	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00118	0.00661	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—SLC5A5—bile duct cancer	0.00116	0.00652	CbGpPWpGaD
Lamivudine—DCK—Metabolism—FAR2—bile duct cancer	0.00115	0.00647	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—IDH1—bile duct cancer	0.00109	0.00615	CbGpPWpGaD
Lamivudine—NME2—Metabolism—IDH2—bile duct cancer	0.00108	0.00608	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.00107	0.006	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.00104	0.00586	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—IDH1—bile duct cancer	0.00102	0.00571	CbGpPWpGaD
Lamivudine—ABCC3—Fluoropyrimidine Activity—TP53—bile duct cancer	0.00101	0.00566	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFBR2—bile duct cancer	0.000994	0.00559	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—SLC5A5—bile duct cancer	0.000978	0.0055	CbGpPWpGaD
Lamivudine—ABCC1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000951	0.00534	CbGpPWpGaD
Lamivudine—ABCC4—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000947	0.00532	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFBR2—bile duct cancer	0.000934	0.00525	CbGpPWpGaD
Lamivudine—NME2—Metabolism—IDH1—bile duct cancer	0.00093	0.00523	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—SMAD4—bile duct cancer	0.000925	0.0052	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—HGF—bile duct cancer	0.000913	0.00513	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000911	0.00512	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—SLC5A5—bile duct cancer	0.000885	0.00497	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—SLC5A5—bile duct cancer	0.000885	0.00497	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—SLC5A5—bile duct cancer	0.000885	0.00497	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—HGF—bile duct cancer	0.000859	0.00483	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000846	0.00476	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000829	0.00466	CbGpPWpGaD
Lamivudine—NME1—Metabolism—IDH2—bile duct cancer	0.000819	0.00461	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TP53—bile duct cancer	0.000799	0.00449	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFBR2—bile duct cancer	0.000788	0.00443	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000754	0.00424	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00074	0.00416	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—FAR2—bile duct cancer	0.000727	0.00408	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—HGF—bile duct cancer	0.000724	0.00407	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—SLC5A5—bile duct cancer	0.000721	0.00406	CbGpPWpGaD
Lamivudine—NME1—Metabolism—IDH1—bile duct cancer	0.000705	0.00396	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000699	0.00393	CbGpPWpGaD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000694	0.0039	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFBR2—bile duct cancer	0.000694	0.0039	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GNAS—bile duct cancer	0.000688	0.00387	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GNAS—bile duct cancer	0.000688	0.00387	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GNAS—bile duct cancer	0.000688	0.00387	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—SLC5A5—bile duct cancer	0.000671	0.00377	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—FAR2—bile duct cancer	0.000668	0.00375	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000662	0.00372	CbGpPWpGaD
Lamivudine—PGK1—Disease—SMAD4—bile duct cancer	0.000657	0.00369	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000636	0.00358	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.00063	0.00354	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000629	0.00353	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	0.000621	0.00349	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000616	0.00346	CbGpPWpGaD
Lamivudine—NME2—Metabolism—SLC5A5—bile duct cancer	0.000613	0.00345	CbGpPWpGaD
Lamivudine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bile duct cancer	0.00061	0.00343	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—TGFB1—bile duct cancer	0.000566	0.00318	CbGpPWpGaD
Lamivudine—DCK—Metabolism—IDH2—bile duct cancer	0.000562	0.00316	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GNAS—bile duct cancer	0.000561	0.00315	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.00054	0.00303	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000531	0.00298	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—FAR2—bile duct cancer	0.000523	0.00294	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GNAS—bile duct cancer	0.000521	0.00293	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000495	0.00278	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000494	0.00277	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000493	0.00277	CbGpPWpGaD
Lamivudine—PGK1—Disease—NOS2—bile duct cancer	0.000489	0.00275	CbGpPWpGaD
Lamivudine—DCK—Metabolism—IDH1—bile duct cancer	0.000483	0.00272	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GNAS—bile duct cancer	0.000477	0.00268	CbGpPWpGaD
Lamivudine—NME1—Metabolism—SLC5A5—bile duct cancer	0.000465	0.00261	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—FAR2—bile duct cancer	0.000461	0.00259	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—FAR2—bile duct cancer	0.000456	0.00256	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00043	0.00242	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—FAR2—bile duct cancer	0.000425	0.00239	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000395	0.00222	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—TGFB1—bile duct cancer	0.000372	0.00209	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000372	0.00209	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PTGS2—bile duct cancer	0.000369	0.00208	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PTGS2—bile duct cancer	0.000369	0.00208	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PTGS2—bile duct cancer	0.000369	0.00208	CbGpPWpGaD
Lamivudine—PGK1—Disease—ERBB2—bile duct cancer	0.000368	0.00207	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GNAS—bile duct cancer	0.000361	0.00203	CbGpPWpGaD
Lamivudine—PGK1—Disease—PTGS2—bile duct cancer	0.00036	0.00202	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—IDH2—bile duct cancer	0.000355	0.00199	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—TGFB1—bile duct cancer	0.00035	0.00197	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000334	0.00188	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—GNAS—bile duct cancer	0.000334	0.00187	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—IDH2—bile duct cancer	0.000326	0.00183	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000323	0.00182	CbGpPWpGaD
Lamivudine—DCK—Metabolism—SLC5A5—bile duct cancer	0.000319	0.00179	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HGF—bile duct cancer	0.000318	0.00179	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000313	0.00176	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00031	0.00174	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000307	0.00173	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RNF43—bile duct cancer	0.000305	0.00172	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—IDH1—bile duct cancer	0.000305	0.00172	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PTGS2—bile duct cancer	0.000301	0.00169	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—TGFB1—bile duct cancer	0.000295	0.00166	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000289	0.00162	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000283	0.00159	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—IDH1—bile duct cancer	0.000281	0.00158	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PTGS2—bile duct cancer	0.00028	0.00157	CbGpPWpGaD
Lamivudine—PGK1—Disease—NRAS—bile duct cancer	0.00028	0.00157	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000272	0.00153	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.00027	0.00152	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IDH1—bile duct cancer	0.000262	0.00148	CbGpPWpGaD
Lamivudine—PGK1—Disease—TGFB1—bile duct cancer	0.00026	0.00146	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PTGS2—bile duct cancer	0.000256	0.00144	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—IDH2—bile duct cancer	0.000256	0.00144	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—bile duct cancer	0.000255	0.00143	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000251	0.00141	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000251	0.00141	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000251	0.00141	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FAR2—bile duct cancer	0.000249	0.0014	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GNAS—bile duct cancer	0.000248	0.00139	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NOS2—bile duct cancer	0.000244	0.00137	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000243	0.00137	CbGpPWpGaD
Lamivudine—PGK1—Disease—KRAS—bile duct cancer	0.000241	0.00135	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000241	0.00135	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	0.000227	0.00127	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—IDH2—bile duct cancer	0.000225	0.00126	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—IDH2—bile duct cancer	0.000223	0.00125	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—IDH1—bile duct cancer	0.00022	0.00124	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000212	0.00119	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00021	0.00118	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—IDH2—bile duct cancer	0.000207	0.00117	CbGpPWpGaD
Lamivudine—PGK1—Disease—HRAS—bile duct cancer	0.000205	0.00115	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SLC5A5—bile duct cancer	0.000201	0.00113	CbGpPWpGaD
Lamivudine—PGK1—Disease—IL6—bile duct cancer	0.000196	0.0011	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000195	0.0011	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PTGS2—bile duct cancer	0.000194	0.00109	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—IDH1—bile duct cancer	0.000193	0.00109	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—IDH1—bile duct cancer	0.000191	0.00108	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SLC5A5—bile duct cancer	0.000185	0.00104	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—IDH1—bile duct cancer	0.000178	0.001	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000173	0.000975	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	0.000158	0.00089	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GNAS—bile duct cancer	0.000156	0.000879	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000155	0.000874	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	0.000155	0.00087	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000147	0.000828	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SLC5A5—bile duct cancer	0.000145	0.000815	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.000145	0.000815	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GNAS—bile duct cancer	0.000144	0.000808	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFBR2—bile duct cancer	0.000139	0.000784	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—NRAS—bile duct cancer	0.000139	0.000783	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000136	0.000764	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—bile duct cancer	0.000133	0.000748	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SMAD4—bile duct cancer	0.000132	0.000742	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TGFB1—bile duct cancer	0.000129	0.000728	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SLC5A5—bile duct cancer	0.000128	0.000717	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SLC5A5—bile duct cancer	0.000126	0.00071	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH2—bile duct cancer	0.000122	0.000684	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—bile duct cancer	0.00012	0.000674	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—bile duct cancer	0.000119	0.00067	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A5—bile duct cancer	0.000118	0.000662	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.000114	0.000643	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GNAS—bile duct cancer	0.000113	0.000633	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	0.000112	0.000629	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—bile duct cancer	0.000111	0.000624	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	0.00011	0.000617	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—bile duct cancer	0.000107	0.000599	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH1—bile duct cancer	0.000105	0.000588	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	0.000104	0.000583	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—bile duct cancer	0.000102	0.000573	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GNAS—bile duct cancer	9.92e-05	0.000557	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—bile duct cancer	9.83e-05	0.000552	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GNAS—bile duct cancer	9.81e-05	0.000552	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	9.21e-05	0.000518	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GNAS—bile duct cancer	9.15e-05	0.000514	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—bile duct cancer	8.4e-05	0.000472	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—bile duct cancer	7.72e-05	0.000434	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—bile duct cancer	7.39e-05	0.000415	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—bile duct cancer	7.23e-05	0.000406	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—bile duct cancer	6.9e-05	0.000388	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—bile duct cancer	6.05e-05	0.00034	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NRAS—bile duct cancer	5.62e-05	0.000316	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNAS—bile duct cancer	5.36e-05	0.000301	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—bile duct cancer	5.33e-05	0.000299	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—bile duct cancer	5.27e-05	0.000296	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—bile duct cancer	5.22e-05	0.000294	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—bile duct cancer	5.12e-05	0.000288	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—bile duct cancer	4.91e-05	0.000276	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—bile duct cancer	4.84e-05	0.000272	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—bile duct cancer	4.11e-05	0.000231	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—bile duct cancer	3.94e-05	0.000221	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—bile duct cancer	2.88e-05	0.000162	CbGpPWpGaD
